YOLFTbeta
22

U2Bio Co., Ltd.

221800 · KQ · Healthcare / Diagnostics & Research

3,300.00KRW+100.00 (+3.13%)

Price History

Full chart

Market Stats

Previous Close3,200.00
Open3,200.00
Day Range3,065.00 – 3,300.00
52-Week Range3,064.57 – 32,800.00
Volume8.65K
Market Cap62.91B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield2.70%
Beta1.39
50-Day Avg4,016.00
200-Day Avg10,062.83

About

ZGOO Holdings Co., Ltd. provides healthcare services in South Korea. The company also offers specimen testing services; digital healthcare services related to testing and health examinations; and bio-technology platforms. The company was formerly known as U2Bio Co., Ltd. and changed its name to ZGOO Holdings Co., Ltd. in April 2026. The company was founded in 2009 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Jin-Tae Kim
  • Employees0
  • Headquarters489, Ogeum-ro, Seoul, South Korea, Korea
  • Websitehttps://www.u2bio.co.kr

Leadership

  • Mr. Jin-Tae KimCEO & Inside Director · b. 1964
  • Mr. Jee Won KimMD, Head of Corporate Culture Strategy Office & Inside Director · b. 1971
  • Mr. Jang Ho ParkHead of Business Division & Inside Director · b. 1970
  • JongGuk KimChief Privacy Officer

Financials

Income Statement

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue50.55B69.01B30.79B25.04B25.59B
Growth (%)-+36.52%-55.38%-18.68%+2.21%
Cost of Revenue34.23B42.37B22.57B20.00B20.20B
Gross Profit16.32B26.64B8.22B5.04B5.39B
Gross Margin32.28%38.60%26.69%20.12%21.08%
Operating Expense7.29B10.95B9.60B8.15B7.59B
Operating Income9.03B15.69B-1.38B-3.11B-2.19B
Operating Margin17.86%22.73%-4.49%-12.43%-8.56%
EBITDA-17.04B993.34M-700.43M-451.01M
EBITDA Margin-24.69%3.23%-2.80%-1.76%
Net Income9.24B13.16B645.90M-2.84B-1.64B
Net Income Margin18.27%19.07%2.10%-11.34%-6.42%
R&D1.78B2.13B1.69B2.11B2.10B
R&D as % of Total Revenue3.51%3.09%5.47%8.43%8.22%
Interest Expense580.60M86.25M36.32M42.62M37.23M
Interest Expense % of Total Revenue1.15%0.12%0.12%0.17%0.15%

Balance Sheet

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets41.33B51.03B49.20B44.98B52.51B
Total Liabilities19.81B17.18B11.21B10.56B10.21B
Total Equity21.52B33.84B37.99B34.43B42.30B
Cash16.48B1.43B35.29B16.49B1.34B

Cash Flow

Currency: KRW2021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow12.75B24.41B-2.55B-1.73B-1.56B
Investing Cash Flow--36.69B33.20B-16.33B-
Financing Cash Flow--2.77B3.21B-737.26M-
Capital Expenditure387.35M1.14B977.89M353.46M201.42M
Free Cash Flow12.36B23.26B-3.53B-2.08B-1.76B
Dividends Paid-757.65M1.26B338.62M-
FCF to OCF96.96%95.32%138.28%120.42%112.89%
Dividend Paid to FCF-3.26%-35.75%-16.24%-

Earnings

Report DateDec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------
EPS Actual-28.07-30.36-2.27-39.83-179.19-22.022.78-66.10-55.89-18.01-227.47
Surprise-----------
Timing-----------

Key Statistics & Ratios

Market Cap62.91B
Enterprise Value46.33B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.46
Price / Book1.03
Revenue (TTM)25.59B
Gross Profit (TTM)5.39B
EBITDA-1.36B
Profit Margin-6.42%
Operating Margin-13.39%
Return on Equity-4.28%
Return on Assets-2.81%
Shares Outstanding16.32M
Shares Float1.01M
Beta1.39
Dividend Yield2.70%
Dividend Rate100.00
Payout Ratio0.00%

Dividends

20251×
100.00Dec 29, 2025
20241×
30.00Dec 27, 2024
20231×
30.00Dec 27, 2023

Stock Splits

  • Feb 23, 20234:1